Outcomes related to 4864 pregnancies with exposure to lopinavir/ritonavir (LPV/r)

INTRODUCTION: During pregnancy, LPV/r is a common anchor drug employed to treat the mother's HIV-1 infection in addition to reducing the risk of mother-to-child transmission (MTCT). The National Study of HIV in Pregnancy and Childhood (NSHPC) conducts a comprehensive population-based surveillan...

Descripción completa

Detalles Bibliográficos
Autores principales: Tookey, Pat, Thorne, Claire, Martinez-Tristani, Marisol, Norton, Michael, van Wyk, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P081
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224945/
https://www.ncbi.nlm.nih.gov/pubmed/25394117
http://dx.doi.org/10.7448/IAS.17.4.19613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224945/
https://www.ncbi.nlm.nih.gov/pubmed/25394117
http://dx.doi.org/10.7448/IAS.17.4.19613

Ejemplares similares